Advanced Biomed (ADVB) Cash & Equivalents (2023 - 2026)
Advanced Biomed's Cash & Equivalents came in at $213,995 for fiscal Q1 2027 (quarter ended Sep 30, 2026), down 91.9% from $2.66 million a year earlier and down 44.5% from the prior quarter.
Powered by 
Analysis
Advanced Biomed (ADVB) Cash & Equivalents (2023 - 2026) Analysis & Trends
At the end of FY2026 (ended Jun 30, 2026), Advanced Biomed's Cash & Equivalents was $385,535, down 86.7% from FY2025.
- Going back by fiscal year, Cash & Equivalents was $2.9 million in FY2025 (+11.3%) and $2.61 million in FY2024.
- The fiscal Q1 2027 figure represents the lowest quarterly Cash & Equivalents in data going back to fiscal Q2 2024.
- Year-over-year, Cash & Equivalents has declined for four consecutive quarters, with an average decline of 16.0% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in fiscal Q3 2025 (growth of 94.6%), and the weakest in fiscal Q1 2027 (a decline of 91.9%).
- Business Quant data shows ADVB's Cash & Equivalents at $385,535 (Q4 2026), $2.61 million (Q3 2026) and $2.61 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.44 Bn | 236.08 Bn | 5.13 Bn | 5.46 Bn |
| 2 | Abbott Laboratories | 187.98 Bn | 162.45 Bn | 7.39 Bn | 4.05 Bn |
| 3 | Danaher | 163.91 Bn | 143.58 Bn | 3.84 Bn | 5.68 Bn |
| 4 | Intuitive Surgical | 153.75 Bn | 134.17 Bn | 2.08 Bn | 2.98 Bn |
| 5 | Medtronic | 131.67 Bn | 97.80 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 117.84 Bn | 104.03 Bn | 4.25 Bn | 3.27 Bn |
| 7 | Boston Scientific | 64.27 Bn | 59.95 Bn | 3.43 Bn | 609.00 Mn |
| 8 | Edwards Lifesciences | 61.69 Bn | 45.00 Bn | 1.35 Bn | 3.11 Bn |
| 9 | Medline | 51.94 Bn | 49.07 Bn | 1.93 Bn | 2.32 Bn |
| 10 | Advanced Biomed | 4.18 Mn | -1.64 Mn | - | 213,995.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 213,995.00 |
| Jun 30, 2026 | 385,535.00 |
| Mar 31, 2026 | 2.61 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.66 Mn |
| Jun 30, 2025 | 2.90 Mn |
| Mar 31, 2025 | 5.18 Mn |
| Dec 31, 2024 | 2.66 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 2.61 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.78 Mn |
API Access
Advanced Biomed Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ADVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ADVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ADVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();